The antitrust controversy swirling around Alphabet, the holding company for Google, just escalated a bit further. A shareholder this week filed a lawsuit that claims senior executives and the board of directors violated their duties to the company by blessing anti-competitive arrangements related to Android software.
In a 53-page complaint filed in state court, shareholder Robert Jessup accuses Alphabet CEO Larry Page, President Sergey Brin, and Executive Chairman Eric Schmidt of mismanagement that could lead to $7.4 billion in fines at the hands of the European Commission, which is suing Google on a raft of antitrust charges.
“For years, the Board has allowed Alphabet to use Android as a Trojan Horse for other services offered by the Company – imposing anticompetitive restrictions on device manufacturers and developers through licensing arrangements for proprietary Android technology and applications,” the complaint reads.
The complaint also names board members, including renowned venture capitalist John Doerr and Stanford University President John Hennessy, as well as members of the firm’s audit committee. The lawsuit asks the defendants to compensate Alphabet for harm the company may suffer as a result of antitrust charges, and it asks the court to shake up Alphabet’s leadership structure.
Full Content: Fortune
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas